Triptans are a family of tryptamine-based drugs used as abortive medication in the treatment of migraines and cluster headaches. This drug class was first introduced in the 1990s. While effective at treating individual headaches, they do not provide preventive treatment and are not considered a cure. 
This report contains market size and forecasts of Triptan in global, including the following market information:
Global Triptan Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Triptan Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Triptan companies in 2021 (%)
The global Triptan market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Triptan include GSK, Teva, Pfizer, Novartis, Sun Pharma, Grunenthal, Endo Pharmaceuticals, Merck and J & J. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Triptan manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Triptan Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Triptan Market Segment Percentages, by Type, 2021 (%)
Oral
Injectable
Global Triptan Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Triptan Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Drug Stores
Global Triptan Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Triptan Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Triptan revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Triptan revenues share in global market, 2021 (%)
Key companies Triptan sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Triptan sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
Teva
Pfizer
Novartis
Sun Pharma
Grunenthal
Endo Pharmaceuticals
Merck
J & J